5 results on '"Azer Kilic Baskan"'
Search Results
2. Long-term Home Mechanical Ventilation of Children in İstanbul
- Author
-
Mürüvvet Yanaz, Füsun Ünal, Evrim Hepkaya, Hakan Yazan, Sinem Can Oksay, Ebru Köstereli, Cansu Yılmaz Yeğit, Azer Kılıç Başkan, Zeynep Reyhan Onay, Aynur Gulieva, Aslınur Soyyiğit, Mine Kalyoncu, Hanife Büşra Küçük, Yetkin Ayhan, Almala Pınar Ergenekon, Emine Atağ, Selçuk Uzuner, Nilay Baş İkizoğlu, Ayşe Ayzıt Kılınç, Pınar Ay, Ela Erdem Eralp, Sedat Öktem, Erkan Çakır, Saniye Girit, Zeynep Seda Uyan, Haluk Çokuğraş, Refika Ersu, Bülent Karadağ, and Fazilet Karakoç
- Subjects
non-invasive ventilation ,neuromuscular disorders ,long-term home mechanical ventilation ,chronic respiratory failure ,Medicine - Abstract
OBJECTIVE: The aims of this multi-center study were to describe the characteristics of children receiving long-term home mechanical ventilation (HMV) in İstanbul and to compare the patients receiving non-invasive and invasive ventilation. MATERIAL AND METHODS: This cross-sectional multicenter study included all children receiving long-term HMV followed by admission to six tertiary hospitals. The data were collected between May 2020 and May 2021. Demographic data and data regarding HMV were collected from the patient charts. RESULTS: The study included 416 participants. The most common diagnoses were neuromuscular (35.1%) and neurological diseases (25.7%). Among the patients, 49.5% (n = 206) received non-invasive ventilation (NIV), whereas 50.5% (n = 210) received invasive ventilation. The median age at initiation was significantly younger in the invasive ventilation group than in the NIV group (10 vs. 41 months, P < 0.001). Most subjects in the NIV group (81.1%) received ventilation support only during sleep, whereas most subjects in the invasive ventilation group (55.7%) received continuous ventilator support (P < 0.001). In addition to ventilation support, 41.9% of the subjects in the invasive ventilation group and 28.6% in the NIV group received oxygen supplementation (P = 0.002). Within the last year, 59.1% (n = 246) of the subjects were hospitalized. The risk factors for hospitalization were invasive ventilation, continuous ventilatory support, oxygen supplementation, tube feeding, and swallowing dysfunction (P = 0.002, 0.009,
- Published
- 2025
- Full Text
- View/download PDF
3. Home Mechanical Ventilation in Children: Experience of Paediatric Pulmonology Divisions in Istanbul
- Author
-
Muruvvet Yanaz, Fusun Unal, Evrim Hepkaya, Sinem Can Oksay, Ebru Köstereli, Cansu Yilmaz Yegit, Azer Kilic Baskan, Zeynep Reyhan Onay, Aynur Gulieva, Aslınur Soyyigit, Mine Kalyoncu, Hanife Busra Kucuk, Yetkin Ayhan, Almala Pinar Ergenekon, Emine Atag, Selcuk Uzuner, Nilay Bas Ikizoglu, Ayse Ayzit Kilinc, Pinar Ay, Ela Erdem Eralp, Yasemin Gokdemir, Sedat Oktem, Erkan Cakir, Saniye Girit, Zeynep Seda Uyan, Haluk Cokugras, Refika Ersu, Bulent Karadag, and Fazilet Karakoc
- Abstract
Advances in technology in recent years increased the long-term survival rate of patients with chronic respiratory failure. As a result, the number of patients receiving long-term home mechanical ventilation (LTHV) support is increasing worldwide. The most important step in the management of patients with home mechanical ventilation (HMV) is to ensure adequate oxygenation and ventilation. Successful care at home requires the presence of trained caregivers and accessibility to medical devices and a care team. The aims of this study were, to describe the characteristics of children on LTHV in Istanbul, to compare the patients receiving non-invasive ventilation (NIV) and invasive ventilation, and to evaluate the frequency and risk factors of hospital admission in this population.
- Published
- 2022
- Full Text
- View/download PDF
4. Comparisons of Clinical Features and Outcomes of COVID-19 between Patients with Pediatric Onset Inflammatory Rheumatic Diseases and Healthy Children
- Author
-
Fatih Haslak, Sevki Erdem Varol, Aybuke Gunalp, Ozge Kaynar, Mehmet Yildiz, Amra Adrovic, Sezgin Sahin, Gulsen Kes, Ayse Ayzit-Kilinc, Beste Akdeniz, Pinar Onal, Gozde Apaydin, Deniz Aygun, Huseyin Arslan, Azer Kilic-Baskan, Evrim Hepkaya, Ozge Meral, Kenan Barut, Haluk Cezmi Cokugras, and Ozgur Kasapcopur
- Subjects
COVID-19 ,SARS-CoV-2 ,rheumatology ,pediatrics ,familial Mediterranean fever ,General Medicine - Abstract
(1) Background: We aimed to describe the clinical features and outcomes of coronavirus disease-2019 (COVID-19) in children and late adolescents with inflammatory rheumatic diseases (IRD) and to measure their severity risks by comparing them with healthy children. (2) Methods: Among children and late adolescents found to be severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) positive via polymerase chain reaction (PCR) test, IRD patients with an at least six-months follow-up duration, and healthy children were included in the study. Data were obtained retrospectively. (3) Results: A total of 658 (339 (51.5%) females) (healthy children: 506, IRD patients: 152) subjects were included in the study. While 570 of 658 (86.6%) experienced COVID-19-related symptoms, only 21 (3.19%) required hospitalization with a median duration of 5 (1–30) days. Fever, dry cough, and fatigue were the most common symptoms. None of evaluated subjects died, and all recovered without any significant sequelae. The presence of any IRD was found to increase the risk of both hospitalization (OR: 5.205; 95% CI: 2.003–13.524) and symptomatic infection (OR: 2.579; 95% CI: 1.068–6.228). Furthermore, increasing age was significantly associated with symptomatic infection (OR: 1.051; 95% CI: 1.009–1.095). (4) Conclusions: Our study emphasizes that pediatric rheumatologists should monitor their patients closely for relatively poor COVID-19 outcomes.
- Published
- 2022
- Full Text
- View/download PDF
5. The success of the Cystic Fibrosis Registry of Turkey for improvement of patient care
- Author
-
Pelin Asfuroglu, Tugba Sismanlar Eyuboglu, Ayse Tana Aslan, Tugba Ramasli Gursoy, Nagehan Emiralioglu, Ebru Yalcin, Nural Kiper, Velat Sen, Hadice Selimoglu Sen, Derya Ufuk Altintas, Dilek Ozcan, Ayse Ayzit Kilinc, Haluk Cokugras, Azer Kilic Baskan, Hakan Yazan, Ufuk Erenberk, Guzide Dogan, Gokcen Unal, Asli Imran Yilmaz, Ozlem Keskin, Elif Arik, Ercan Kucukosmanoglu, Ilim Irmak, Ebru Damadoglu, Gokcen Kartal Ozturk, Figen Gulen, Abdurrahman Erdem Basaran, Aysen Bingol, Sukru Cekic, Nihat Sapan, Gonca Kilic, Koray Harmanci, Mehmet Kose, Ali Ozdemir, Gokcen Dilsa Tugcu, Sanem Eryilmaz Polat, Melih Hangul, Gizem Ozcan, Zeynep Gokce Gayretli Aydin, Hasan Yuksel, Erdem Topal, Sebnem Ozdogan, Gonul Caltepe, Ayse Suleyman, Demet Can, Pervin Korkmaz Ekren, Cem Murat Bal, Mehmet Kilic, Guzin Cinel, Nazan Cobanoglu, Sevgi Pekcan, Erkan Cakir, Ugur Ozcelik, Deniz Dogru, Dicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı, Şen, Velat, Şen, Hadice Selimoğlu, and ÇAKIR, Erkan
- Subjects
Male ,Pulmonary and Respiratory Medicine ,Registry ,child ,Turkey ,Infant, Newborn ,Bartter Syndrome ,Cystic Fibrosis Transmembrane Conductance Regulator ,Growth ,registry ,Cystic fibrosis ,cystic fibrosis ,Asfuroglu P., Sismanlar Eyuboglu T., Aslan A. T. , Gursoy T. R. , Emiralioglu N., Yalcin E., Kiper N., Sen V., Sen H. S. , Altintas D. U. , et al., -The Success of the Cystic Fibrosis Registry of Turkey for Improvement of Patient Care.-, Pediatric pulmonology, 2022 ,Pediatrics, Perinatology and Child Health ,Humans ,Female ,Patient Care ,Registries ,Child - Abstract
© 2022 Wiley Periodicals LLC.Background: Cystic fibrosis (CF) registries play an essential role in improving disease outcomes of people with CF. This study aimed to evaluate the association of newly established CF registry system in Turkey on follow-up, clinical, growth, treatment, and complications of people with this disease. Methods: Age at diagnosis, current age, sex, z-scores of weight, height and body mass index (BMI), neonatal screening results, pulmonary function tests, history of meconium ileus, medications, presence of microorganisms, and follow-up were evaluated and compared to data of people with CF represented in both 2017 and 2019 registry data. Results: There were 1170 people with CF in 2017 and 1637 in 2019 CF registry. Eight hundred and fourteen people were registered in both 2017 and 2019 of whom z-scores of heights and BMI were significantly higher in 2019 (p = 0.002, p =0.039, respectively). Inhaled hypertonic saline, bronchodilator, and azithromycin usages were significantly higher in 2019 (p =0.001, p = 0.001, p = 0.003, respectively). The percent predicted of forced expiratory volume in 1 sec and forced vital capacity were similar in 2017 and 2019 (88% and 89.5%, p = 0.248 and 84.5% and 87%, p =0.332, respectively). Liver diseases and osteoporosis were significantly higher, and pseudo-Bartter syndrome (PBS) was significantly lower in 2019 (p = 0.011, p = 0.001, p = 0.001, respectively). Conclusions: The z-scores of height and BMI were higher, the use of medications that protect and improve lung functions was higher and incidence of PBS was lower in 2019. It was predicted that registry system increased the care of people with CF regarding their follow-up. The widespread use of national CF registry system across the country may be beneficial for the follow-up of people with CF.
- Published
- 2022
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.